Cas No.: | 77257-42-2 |
Chemical Name: | Ethanaminium,N,N,N-triethyl-2-[4-[(1E)-2-phenylethenyl]phenoxy]-, iodide (1:1) |
Synonyms: | Ethanaminium,N,N,N-triethyl-2-[4-[(1E)-2-phenylethenyl]phenoxy]-, iodide (1:1);MG 624;MG 624,N,N,N-Triethyl-2-[4-(2-phenylethenyl)phenoxy]ethanaminiumiodide;CCK Octapeptide,non-sulfated;Stilonium;Stilonium iodide;N,N,N-Triethyl-2-(4-trans-stilbenoxy)ethylammonium iodide |
SMILES: | [I-].CC[N+](CCOC1C=CC(/C=C/C2C=CC=CC=2)=CC=1)(CC)CC |
Formula: | C22H30NO+.I- |
M.Wt: | 451.3837 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A selective antagonist of α7 nAChR that inhibits α-Bgtx binding to α7 with Ki of 106 nM; also inhibits ACh elicited currents (I(ACh)) in the oocyte-expressed α7 with IC50 of 109 nM; potently suppresses the proliferation of primary human microvascular endothelial cells of the lung (HMEC-Ls), decreases nicotine-induced early growth response gene 1 (Egr-1) levels in HMEC-Ls, and reduces the levels of Egr-1 on the FGF2 promoter; inhibits angiogenesis of human SCLC tumors in mice. |